Captrust Financial Advisors Axonics, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $444 - $573	-9 Reduced 0.25%	3,574 $222,000
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $174,277 - $223,973	3,583 New	3,583 $201,000
Q2 2022 Aug 23, 2022	SELL	$39.5 - $64.42 $4,937 - $8,052	-125 Reduced 11.66%	947 $54,000
Q2 2022 Aug 16, 2022	BUY	$39.5 - $64.42 $14,457 - $23,577	366 Added 51.84%	1,072 $61,000
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $12,115 - $17,384	277 Added 64.57%	706 $44,000
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $4,650 - $6,821	93 Added 27.68%	429 $24,000
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $11,105 - $13,535	226 Added 205.45%	336 $20,000
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $2,520 - $4,381	110 New	110 $4,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.